ATE315229T1 - Komplex aus n-glykolisierten proteinen (siblings) und faktor h - Google Patents

Komplex aus n-glykolisierten proteinen (siblings) und faktor h

Info

Publication number
ATE315229T1
ATE315229T1 AT00923174T AT00923174T ATE315229T1 AT E315229 T1 ATE315229 T1 AT E315229T1 AT 00923174 T AT00923174 T AT 00923174T AT 00923174 T AT00923174 T AT 00923174T AT E315229 T1 ATE315229 T1 AT E315229T1
Authority
AT
Austria
Prior art keywords
siblings
proteins
factor
provides methods
glycolized
Prior art date
Application number
AT00923174T
Other languages
English (en)
Inventor
Larry W Fisher
Neal S Fedarko
Marian F Young
Original Assignee
Us Gov Health & Human Serv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22435520&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE315229(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Us Gov Health & Human Serv filed Critical Us Gov Health & Human Serv
Application granted granted Critical
Publication of ATE315229T1 publication Critical patent/ATE315229T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G01N2333/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/108—Osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT00923174T 1999-04-09 2000-04-07 Komplex aus n-glykolisierten proteinen (siblings) und faktor h ATE315229T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12846899P 1999-04-09 1999-04-09

Publications (1)

Publication Number Publication Date
ATE315229T1 true ATE315229T1 (de) 2006-02-15

Family

ID=22435520

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00923174T ATE315229T1 (de) 1999-04-09 2000-04-07 Komplex aus n-glykolisierten proteinen (siblings) und faktor h

Country Status (6)

Country Link
EP (1) EP1169642B1 (de)
AT (1) ATE315229T1 (de)
AU (1) AU769185B2 (de)
CA (1) CA2370018A1 (de)
DE (1) DE60025342D1 (de)
WO (1) WO2000062065A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1399482T3 (da) 2001-06-13 2009-07-20 Immundiagnostik Ag Bestemmelse af bone-sialoprotein i kropsvæsker til on-kologiske problemstillinger
AU2002319223A1 (en) * 2001-06-13 2002-12-23 Osteopep-Pharma Gmbh Medicament for treating tumours and their metastases using a binding molecule against bone-sialoprotein
US7678889B2 (en) 2002-08-06 2010-03-16 Diadexus, Inc. Compositions and methods relating to ovarian specific genes and proteins
WO2006128689A2 (de) 2005-05-31 2006-12-07 Ralf Jochem Therapeutsche zusammensetzung zur vorbeugung und bekämpfung von knochenmetastasen
EP2269663B1 (de) 2009-07-03 2018-03-07 Armbruster Biotechnology GmbH Knochenimplantat und bioverbundstoff

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5340934A (en) * 1989-11-03 1994-08-23 The United States Of Americas As Represented By The Secretary Of Health & Human Services CDNA sequences of human bone matrix proteins
JPH09138213A (ja) * 1995-11-15 1997-05-27 Sangi Co Ltd 免疫センサ
ES2532610T3 (es) * 2004-07-26 2015-03-30 Genentech, Inc. Procedimientos y composiciones para modular la activación del factor de crecimiento de hepatocitos

Also Published As

Publication number Publication date
DE60025342D1 (de) 2006-03-30
AU4334100A (en) 2000-11-14
EP1169642B1 (de) 2006-01-04
CA2370018A1 (en) 2000-10-19
WO2000062065A1 (en) 2000-10-19
EP1169642A1 (de) 2002-01-09
WO2000062065B1 (en) 2001-01-25
AU769185B2 (en) 2004-01-15

Similar Documents

Publication Publication Date Title
ATE354588T1 (de) Verfahren und zusammestellungen zum nachweis und behandlung von brustkrebs, beruhend auf brustkrebs-assoziierten polypeptiden
TR200101482T2 (tr) WT1'e özgü imünoterapi için bileşimler
AU4073297A (en) Methods and compositions for the detection of cervical cancer
TR200002284T2 (tr) Mage ailesinden tümör ile ilgili tümör türevleri
ATE454468T1 (de) Nachweis der instabilität von mikrosatelliten und verwendung davon bei der tumordiagnose
ATE451390T1 (de) Polypeptide zur bindung an das b-lymphozyten- stimulatorische protein (blys)
ATE480643T1 (de) Homogener nachweis von analyten
WO2002061129A3 (en) Oligonucleotide identifiers
TR200000115T2 (tr) Tüberkülozun immünoterapi ve teşhisi için bileşikler ve bu bileşiklerin kullanımı için yöntemler.
BR0211200A (pt) Peptìdeos efetivos no tratamento de tumores e outras condições que requerem a remoção ou destruição de células
ATE481645T1 (de) Biomarker für den frühzeitigen nachweis von ovarialkarzinom
WO2005113838A3 (en) Detection of protein translocation by beta-galactosidase reporter fragment complementation
WO2004066958A3 (en) Caspase-9:bir3 domain of xiap complexes and methods of use
WO2005019470A3 (en) Detecting and profiling molecular complexes
WO1999045098A3 (en) Delivery or proteins into eukaryotic cells with recombinant yersinia
WO2002063271A3 (en) Activity based probe analysis
WO2001025791A3 (en) Prostate cancer marker proteins
DE60025342D1 (de) Komplex aus n-glykolisierten proteinen (siblings) und faktor h
Yano et al. SYT–SSX fusion genes in synovial sarcoma of the thorax
ATE406094T1 (de) Identifizierung und charakterisierung von genen
EP2083018A3 (de) Zusammensetzungen und Verfahren mit Bezug zu STOP-1
WO2004074325A3 (en) Compositions and methods for the detection and treatment of methylthioadenosine phosphorylase deficient cancers
WO2006063009A3 (en) Diagnosis of hyperinsulinemia and type ii diabetes and protection against same based on proteins differentially expressed in serum
ATE399176T1 (de) Nonapeptidische ny-eso-1 derivate und deren verwendung
WO2002078636A3 (en) Detection and treatment of colorectal cancer

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties